For research use only. Not for therapeutic Use.
Deoxycholic Acid-d5(Cat No.:R052191) is a deuterated form of deoxycholic acid, where five hydrogen atoms are replaced with deuterium. This isotopic modification enhances the compound’s stability and resistance to metabolic degradation, making it highly valuable for analytical studies, particularly in the investigation of bile acid metabolism and its role in digestion and cholesterol regulation. Deoxycholic acid is a secondary bile acid involved in the breakdown of fats. The deuterated version, Deoxycholic Acid-d5, facilitates more precise and accurate measurements in pharmacokinetic and metabolic research, improving our understanding of bile acid-related disorders and potential therapeutic interventions.
Catalog Number | R052191 |
CAS Number | 52840-14-9 |
Synonyms | 3α,12α-Dihydroxy-5β-cholanic Acid-d5; 3α,12α-Dihydroxy-5β-cholanoic Acid-d5; 3α,12α-Dihydroxycholanic Acid-d5; 5β-Cholanic Acid-3α,12α-diol-d5; 5β-Deoxycholic Acid-d5; 7-Deoxycholic Acid-d5; Cholerebic-d5; Cholorebic-d5; Degalol-d5; Deoxycholatic Aci |
Molecular Formula | C24H40O4 |
Purity | ≥95% |
Target | Metabolic Enzyme/Protease |
Storage | Room temperature |
IUPAC Name | (4R)-4-[(3R,5R,10S,12S,13R,14S,17R)-2,2,3,4,4-pentadeuterio-3,12-dihydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid |
InChI | InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17?,18-,19+,20?,21+,23+,24-/m1/s1/i10D2,12D2,16D |
InChIKey | KXGVEGMKQFWNSR-JTHHUVBGSA-N |
SMILES | [2H][C@]1(C(C[C@]2([C@@H](C1([2H])[2H])CCC3C2C[C@@H]([C@]4([C@H]3CC[C@@H]4[C@H](C)CCC(=O)O)C)O)C)([2H])[2H])O |